EliseAI, a New York-based automation platform serving real estate and healthcare, is in advanced talks to raise $300 million at a $3.7 billion valuation, with Andreessen Horowitz and Bessemer Venture Partners discussing lead roles in the round. If the funding closes as reported, the company would add roughly $1.5 billion in value within a single year, a pace that stands out even as many AI startups struggle to raise capital.

What Makes EliseAI's Growth Trajectory Remarkable?

EliseAI's valuation has accelerated dramatically over the past 24 months. The company reached a $1 billion valuation in August 2024 following a $75 million Series D led by Sapphire Ventures. Just one year later, in August 2025, it closed a $250 million Series E at a $2.2 billion valuation, again with Andreessen Horowitz leading. The current funding round would represent a 68% increase from that valuation in less than a year.

This growth reflects the company's expanding footprint across two major industries. EliseAI says its automation platform now touches roughly one in eight apartments across the United States, giving it substantial scale in residential leasing before it ever expanded into healthcare. The company surpassed $100 million in annualized recurring revenue in early 2025, a milestone driven largely by its real estate business before healthcare began contributing more meaningfully to overall growth.

How Does EliseAI's Platform Actually Work?

• Real Estate Automation: The platform acts as an automated operational layer for property management, handling end-to-end tenant communication, scheduling apartment tours, and processing maintenance requests without requiring constant human intervention from leasing and property management staff.
• Healthcare Integration: EliseAI extended its approach into healthcare starting in 2022, focusing on outpatient specialties such as dermatology and women's health. The platform integrates directly with electronic health record systems to automate appointment scheduling, patient communications, and compliance-related tasks.
• Operational Efficiency: Both applications target the same underlying problem: reducing administrative burden on staff by automating repetitive, manual workflows that consume significant time and resources.

EliseAI was founded in 2017 by chief executive Minna Song and chief technology officer Tony Stoyanov, who met as undergraduates at Cambridge. Song has described the company's origin story taking shape after she worked as an administrative assistant at a New York real estate firm, where she observed leasing teams repeatedly answering the same narrow set of tenant questions day after day. That pattern convinced her the work was ripe for automation.

Why Are Investors Betting on Vertical AI Platforms?

EliseAI's continued ability to raise larger rounds at steeper valuations, even as some corners of the AI funding market cool, suggests investors view the company's combination of real revenue, high customer penetration in real estate, and an expanding healthcare vertical as a durable position rather than a speculative bet on future potential. The reported talks arrive at a moment when investor appetite for proven vertical AI companies remains strong, even as funding for earlier-stage or less differentiated AI startups has grown more selective.

Investors backing the deal appear to be betting on a thesis that specialized, vertical-specific AI platforms addressing deep, industry-specific operational pain points can outcompete broader general-purpose AI tools within their chosen domains. This approach contrasts with the broader AI market, where many startups have struggled to demonstrate defensible advantages against larger, more generalized competitors.

Should the new round close as reported, EliseAI has said the fresh capital would go toward further scaling its core real estate automation systems while aggressively accelerating its push into healthcare, treating the sector not as a side experiment but as a second major growth pillar alongside its original housing business. The company's headcount has grown accordingly, climbing from around 150 employees at the time of its Series D to more than 300 today, with staff spread across offices in New York, San Francisco, Boston, and Chicago.

Neither EliseAI, Andreessen Horowitz, nor Bessemer Venture Partners have commented publicly on the reported talks, and the terms remain unsettled. However, the scale of investor interest being reported points to continued conviction in EliseAI's approach to automating some of the most tedious, repetitive operational work inside two of the economy's largest and most essential industries.